The Asia Pacific intrauterine contraceptive devices market is predicted to grow at the highest CAGR of 4.26% over the forecast period of 2019-2027, generating $XX billion by the end of 2027. Intrauterine Device (IUD), also referred to as Intrauterine Contraceptive Devices (ICD), is a T-shaped, small device which is injected into a woman’s uterus to prevent contraception. The devices are available as Hormonal ICD and copper ICD. The numerous applications of the devices in the Asia Pacific region include preventing endometrial cancer risk, such as the risk of developing two primary types of cervical cancer, birth control, etc. As a result of this rising utilizations, the market of intrauterine contraceptive devices is estimated to further grow throughout the projected period. Also, there is a minimum risk of cervical cancer to the women who use intrauterine contraceptive devices as a birth control measure.

ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICES MARKET FORECAST 2019-2027

Asia Pacific Intrauterine Contraceptive Devices Market by Type (Copper Icd, Hormonal Icd) by Product (Mirena, Skyla, Paragard, Other Products) by Geography.

Request free sample

The Asia Pacific intrauterine contraceptive devices market is predicted to grow at the highest CAGR of 4.26% over the forecast period of 2019-2027, generating $XX billion by the end of 2027. Intrauterine Device (IUD), also referred to as Intrauterine Contraceptive Devices (ICD), is a T-shaped, small device which is injected into a woman’s uterus to prevent contraception. The devices are available as Hormonal ICD and copper ICD.

The numerous applications of the devices in the Asia Pacific region include preventing endometrial cancer risk, such as the risk of developing two primary types of cervical cancer, birth control, etc. As a result of this rising utilizations, the market of intrauterine contraceptive devices is estimated to further grow throughout the projected period. Also, there is a minimum risk of cervical cancer to the women who use intrauterine contraceptive devices as a birth control measure.

The countries like China, India, Japan, South Korea, and Australia, along with the Rest of Asia Pacific, were analyzed for the required market study. It was established that China has the highest potential to flourish in the Asia Pacific region. The market is mainly segmented based on products and types. Factors such as the increasing awareness and acceptance of IUD in the country, coupled with the various government ordinances coordinating with the numerous educational institutes to eliminate the unintentional teen pregnancy in the region is successfully propelling the IUD market ahead.

Some of the well-known companies in the market include SMB Corporation, Allergan PLC, Krishco Medical Products Pvt. Ltd., Merck & Co., Zhejiang Daji Medical Instruments Co., Ltd., Egemen International, Pregna, OCON Medical Ltd., Bayers AG, HLL LifeCare Ltd., Melbea, Meril Life Sciences Pvt. Ltd., DKT International, Teva Pharmaceutical Industries Limited, Medicines360, Pfizer, Trimedic Supply Network Ltd., Mona Lisa N.V., Okamoto Industries Inc., and others.

 

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE
      • STUDY GOALS
      • SCOPE OF THE MARKET STUDY
      • WHO WILL FIND THIS REPORT USEFUL?
      • STUDY AND FORECASTING YEARS
    2. RESEARCH METHODOLOGY
      • SOURCES OF DATA
        • SECONDARY DATA
        • PRIMARY DATA
      • TOP-DOWN APPROACH
      • BOTTOM-UP APPROACH
      • DATA TRIANGULATION
    3. EXECUTIVE SUMMARY
      • MARKET SUMMARY
      • KEY FINDINGS
        • INCREASED FUNDING IS SUPPORTING PUBLIC AWARENESS
        • ASIA PACIFIC TO LEAD THE INTRAUTERINE CONTRACEPTIVE DEVICE MARKET
        • INTRAUTERINE CONTRACEPTIVE DEVICE HAVE A LOW FAILURE RATE
        • COPPER IUD HOLD THE LARGEST MARKET SHARE
    1. MARKET DYNAMICS
      • MARKET SCOPE & DEFINITION
      • MARKET DRIVERS
        • RISING PREVALENCE OF UNPLANNED PREGNANCY
        • TECHNOLOGICAL ADVANCEMENTS IN INTRAUTERINE CONTRACEPTIVE DEVICES
        • GOVERNMENT INITIATIVES FOCUSING ON IMPROVED HEALTHCARE IN ASIAN COUNTRIES
      • MARKET RESTRAINTS
        • HIGH COST OF TREATMENT
        • LOW ADOPTION OF INTRAUTERINE CONTRACEPTION IN DEVELOPING COUNTRIES
      • MARKET OPPORTUNITIES
        • RATE OF UNINTENDED PREGNANCIES IS VERY HIGH
        • VERY LOW FAILURE RATE OF IUD AND LOW SIDE-EFFECTS
      • MARKET CHALLENGES
        • HIGH RISK OF ECTOPIC PREGNANCY
    1. MARKET BY TYPE
      • COPPER ICD
      • HORMONAL ICD
    2. MARKET BY PRODUCT
      • MIRENA
      • SKYLA
      • PARAGARD
      • OTHER PRODUCTS
    3. KEY ANALYTICS
      • PORTER’S FIVE FORCE MODEL
        • THREAT OF NEW ENTRANTS
        • THREAT OF SUBSTITUTE
        • BARGAINING POWER OF SUPPLIERS
        • BARGAINING POWER OF BUYERS
        • THREAT OF COMPETITIVE RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    4. GEOGRAPHICAL ANALYSIS
      • ASIA PACIFIC
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • AUSTRALIA
        • REST OF ASIA PACIFIC
    1. COMPETITIVE LANDSCAPE
      • COMPANY PROFILES
        • ALLERGAN PLC
        • BAYERS AG
        • HLL LIFECARE LTD.
        • PFIZER
        • MERCK & CO.
        • OCON MEDICAL LTD.
        • DKT INTERNATIONAL
        • PREGNA
        • SMB CORPORATION
        • OKAMOTO INDUSTRIES INC.
        • TEVA PHARMACEUTICAL INDUSTRIES LIMITED
        • EGEMEN INTERNATIONAL
        • MEDISAFE DISTRIBUTION INC.
        • MELBEA
        • KRISHCO MEDICAL PRODUCTS PVT. LTD.
        • ZHEJIANG DAJI MEDICAL INSTRUMENTS CO., LTD.
        • MERIL LIFE SCIENCES PVT. LTD.
        • MONA LISA N.V.
        • TRIMEDIC SUPPLY NETWORK LTD.
        • MEDICINES360

     

    TABLE LIST

    TABLE 1. ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2019-2027 (IN $ BILLION)

    TABLE 2. ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2019-2027 (IN $ BILLION)

    TABLE 3. ASIA PACIFIC COPPER ICD MARKET, BY REGION, 2019-2027 (IN $ BILLION)

    TABLE 4. ASIA PACIFIC HORMONAL ICD MARKET, BY REGION, 2019-2027 (IN $ BILLION)

    TABLE 5. ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY PRODUCT, 2019-2027 (IN $ BILLION)

    TABLE 6. ASIA PACIFIC MIRENA MARKET, BY REGION, 2019-2027 (IN $ BILLION)

    TABLE 7. ASIA PACIFIC HARDWARE MARKET, BY REGION, 2019-2027 (IN $ BILLION)

    TABLE 8. ASIA PACIFIC PARAGARD MARKET, BY REGION, 2019-2027 (IN $ BILLION)

    TABLE 9. ASIA PACIFIC OTHER PRODUCTS MARKET, BY REGION, 2019-2027 (IN $ BILLION)

    TABLE 10. OPPORTUNITY MATRIX

    TABLE 11. VENDOR LANDSCAPE

    TABLE 12. ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2019-2027 (IN $ BILLION)

    TABLE 15. ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY COUNTRY, 2019-2027 (IN $ BILLION)

     

    FIGURE LIST

    FIGURE 1. ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2018 & 2027 (IN %)

    FIGURE 2. ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY COPPER ICD, 2019-2027 (IN $ BILLION)

    FIGURE 3. ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY HORMONAL ICD, 2019-2027 (IN $ BILLION)

    FIGURE 4. ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY MIRENA, 2019-2027 (IN $ BILLION)

    FIGURE 1. ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY SKYLA, 2019-2027 (IN $ BILLION)

    FIGURE 2. ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY PARAGARD, 2019-2027 (IN $ BILLION)

    FIGURE 3. ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY OTHER PRODUCTS, 2019-2027 (IN $ BILLION)

    FIGURE 4. PORTER’S FIVE FORCE ANALYSIS

    FIGURE 5. ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)

    FIGURE 14. CHINA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)

    FIGURE 15. JAPAN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)

    FIGURE 16. INDIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)

    FIGURE 17. SOUTH KOREA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)

    FIGURE 18. AUSTRALIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)

    FIGURE 19. REST OF ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)

    1. GEOGRAPHICAL ANALYSIS
      • ASIA PACIFIC
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • AUSTRALIA
        • REST OF ASIA PACIFIC
    1. MARKET BY TYPE
      • COPPER ICD
      • HORMONAL ICD
    2. MARKET BY PRODUCT
      • MIRENA
      • SKYLA
      • PARAGARD
      • OTHER PRODUCTS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type